Figure 2. Subgroup Analysis of Major Adverse Cardiac and Cerebrovascular Events (MACCEs) Between Patients With Non–Small Cell Lung Cancers (NSCLC) Receiving vs Not Receiving Tyrosine Kinase Inhibitors (TKIs).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.